The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Outcomes of HIV-positive lymphoma patients treated in the highly active antiretroviral therapy (HAART) era.
M. A. Fanale
No relevant relationships to disclose
K. Vigil
No relevant relationships to disclose
C. Lai
No relevant relationships to disclose
L. Feng
No relevant relationships to disclose
W. Dong
No relevant relationships to disclose
A. Younes
No relevant relationships to disclose
J. E. Romaguera
Research Funding - Celgene; Millennium; Wyeth
L. Fayad
No relevant relationships to disclose
F. B. Hagemeister
No relevant relationships to disclose
V. Mulanovich
No relevant relationships to disclose